Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 6

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 net cash used in operating activities: 

    Depreciation and amortization 
     190  
     24 
  
    Unrealized loss on foreign currency remeasurement 
     273  
     - 
  
    Non-cash expense of ELOC commitment 
     1,095  
     - 
  
    Share-based compensation expense 
     894  
     3,471 
  
    Change in fair value of warrant liabilities 
     103  
     - 
  
    Change in fair value of convertible rights 
     179  
     - 
  
    Non-cash interest expense 
     176  
     - 
  
    Change in operating assets and liabilities: 

    Prepaid expenses and other current assets 
     146  
     (5,883)
  
    R&D tax incentive 
     2,627  
     - 
  
    Assets pledged as securities for short-term debt 
     (1,383) 
     - 
  
    Trade and other payables 
     (859) 
     504 
  
    Net cash used in operating activities 
     (7,872) 
     (7,852)
  
    Cash flows from investing activities: 

    Purchase of property, plant and equipment 
     (8) 
     (280)
  
    Net cash used in investing activities 
     (8) 
     (280)
  
    Cash flows from financing activities: 

    Proceeds received from facility agreement 
     4,282  
     - 
  
    Repayment of facility agreement 
     (2,898) 
     - 
  
    Proceeds from issuance of convertible debt 
     2,779  
     - 
  
    Debt issuance costs 
     (113) 
     - 
  
    Net cash provided by financing activities 
     4,050  
     - 

    Effect of exchange rate changes on cash and cash equivalents 
     70  
     567 
  
    Net decrease in cash and cash equivalents 
     (3,830) 
     (8,132)
  
    Cash and cash equivalents at beginning of period 
     5,858  
     22,120 
  
    Cash and cash equivalents at end of period 
    $2,098  
    $14,555 

    Non-c